Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | +8613726739909 |
| E-mail: | pengguizi@cti-cert.com |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Ruxolitinib Impurity 13 | C7H6ClN3O | 2821844-77-1 | Details |
| Orforglipron Impurity 1 | C40H43FN8O5 | 2212020-29-4 | Details |
| Ruxolitinib Impurity 24 | C23H29N5O4 | Details |
| Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
| Osimertinib | C28H33N7O2 | 1421373-65-0 | Details |
| Enzalutamide Impurity04 | C20H18F4N4O2 | 1289942-55-7 | Details |
| Enzalutamide Impurity08 | C21H18F4N4O3S | 2030242-21-6 | Details |
| Aztreonam Dimer Impurity 2 | Details |
| 1H-Pyrazole-5-carboxylic acid, 1-(2-amino-2-oxoethyl)- | C6H7N3O3 | 1318758-40-5 | Details |
| Ruxolitinib Impurity 34 | C23H28N6O2 | 1236033-23-0 | Details |
| 6-bromobenzo[cd]indol-2(1H)-one | C11H6BrNO | 24856-00-6 | Details |
| Nilotinib Impurity12 | C28H22F3N7O | 641571-05-3 | Details |
| Ruxolitinib Impurity 25 | C23H28N6O2 | 1236033-05-8 | Details |
| Nilotinib Impurity15 | C19H17F3N4O | 915711-42-1 | Details |
| NORTRIPTYLINE | C19H21N | 72-69-5 | Details |
| Ruxolitinib Impurity 15 | 136543-69-5 | Details |
| Gepotidacin Impurity 23 | 1075236-59-7 | Details |
| Nilotinib Impurity05 | C27H20F3N7O | 2119583-26-3 | Details |
| Enzalutamide Impurity07 | C22H18F4N4O2S | 1443331-78-9 | Details |
| Ruxolitinib Impurity 23 | C23H30N6O3 | 1236032-96-4 | Details |
| Ruxolitinib Impurity 29 | C17H20N6O | 2102675-42-1 | Details |
| Gepotidacin Impurity 26 | 1075236-51-9 | Details |
| Nilotinib Impurity11 | C28H22F3N7O2 | 1246817-85-5 | Details |
| 4-(2,5-dibromophenoxy)butanoic acid | C9H17NO4 | 3783-61-7 | Details |
| Enzalutamide Impurity03 | C17H12F4N4OS | 1798807-39-2 | Details |
| Orforglipron Impurity 2 | C22H25N3O5 | 2212021-83-3 | Details |
| Ruxolitinib Impurity 18 | C8H12O2 | 117929-79-0 | Details |
| Gepotidacin Impurity 2 | C24H28N6O3 | 2319789-82-5 | Details |
| Gepotidacin Impurity 14 | 1075236-90-6 | Details |
| Enzalutamide Impurity06 | C20H14F4N4O2S | 1242137-16-1 | Details |
| Enzalutamide Impurity05 | C20H13F4N3O3S | 1242137-15-0 | Details |
| Nilotinib Impurity10 | C28H27F3N6O2 | Details |
| 3-QUINUCLIDINONE HCl | C7H12ClNO | 173075-53-1 | Details |
| Nilotinib Impurity03 | C20H19F3N6O | 1345336-53-9 | Details |
| Nilotinib Impurity13 | C29H24F3N7O | 2119583-25-2 | Details |
| Verapamilic Acid | C16H21NO4 | 36622-23-8 | Details |
| (1-bromocyclopentyl)(2-chlorophenyl)methanone | C12H12BrClO | 6740-86-9 | Details |
| Ruxolitinib Impurity 17 | C8H13NO | 1000538-32-8 | Details |
| Ruxolitinib Impurity 19 | C10H9N5O | Details |
| 1-(1-methyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)cyclopropane-1-carboxamide | Details |
| Gepotidacin Impurity 27 | 1075236-49-5 | Details |
| Gepotidacin Impurity 20 | 1075236-68-8 | Details |
| ethyl 1-(cyanomethyl)-1H-pyrazole-5-carboxylate | C8H9N3O2 | 1217862-66-2 | Details |
| 3-QUINUCLIDINONE | C7H11NO | 3731-38-2 | Details |
| 1H-Pyrazole-5-carboxylic acid, 1-(2-amino-2-oxoethyl)-, ethyl ester | C8H11N3O3 | 2127110-18-1 | Details |
| Ruxolitinib Impurity 14 | C12H13Cl2N3O2 | 1643967-75-2 | Details |
| Ruxolitinib Impurity 22 | C15H16N6O3 | Details |
| Ruxolitinib Impurity 32 | C17H18N6O | Details |
| Nilotinib Impurity01 | C17H14N4O2 | 641569-94-0 | Details |
| Gepotidacin Impurity 25 | 1075236-54-2 | Details |
| Aztreonam and Arginine Polymerization Impurity | Details |
| Ruxolitinib Impurity 31 | C8H11N | 591769-05-0 | Details |
| Alectinib | C30H34N4O2 | 1256580-46-7 | Details |
| 3-(tert-Butoxycarbonyl-ethoxycarbonylmethyl-amino) -propionic acid ethyl ester | C14H25NO6 | 146256-97-5 | Details |
| β-Nicotinamide | C11H15N2O8P | 1094-61-7 | Details |
| Enzalutamide Impurity02 | C21H17F3N4O2S | 915087-16-0 | Details |
| Aceclidine | C9H15NO2 | 827-61-2 | Details |
| Pyrazolo[1,5-a]pyrazine-4,6(5H,7H)-dione | C6H5N3O2 | 2127110-19-2 | Details |
| 1-(4-fluorophenyl)-1,3-dihydro-1-[3-(methylamino)propyl]isobenzofuran-5-carbonitrile | C19H19FN2O | 62498-67-3 | Details |
| Ruxolitinib Impurity 16 | C7H12N2O | 2228423-28-5 | Details |
| Ruxolitinib Impurity 20 | C14H17N5O2 | 2761352-71-8 | Details |
| Gepotidacin Impurity 1 | C24H28N6O3 | 1808797-88-7 | Details |
| Orforglipron Impurity 3 HCl | C18H20FN5O.ClH | 2212021-63-9 | Details |
| Seladelpar Impurity 7 | C21H23F3O5S | 851528-85-3 | Details |
| Crizotinib Impurity02 | C21H23Cl2N5O | Details |
| Nilotinib Impurity04 | C28H22F3N7O | 641571-15-5 | Details |
| N-desmethyl-promethazine | C16H18N2S | 37707-23-6 | Details |
| Tofacitinib Impurity 09 | C7H16N2 | 1354469-76-3 | Details |
| Nilotinib Impurity07 | C29H24F3N7O | 2119583-24-1 | Details |
| 4,6-dichloropyrazolo[1,5-a]pyrazine | C6H3Cl2N3 | 2127110-20-5 | Details |
| Enzalutamide Impurity09 | C13H10F3N3OS | 143782-28-9 | Details |
| Osimertinib Impurity 08 | C31H35N7O3 | 1932710-29-6 | Details |
| Nilotinib Impurity09 | C28H22F3N7O2 | 2139382-75-3 | Details |
| Tofacitinib Impurity 04 | C7H10N2 | 77862-24-9 | Details |
| Crizotinib Impurity08 | C29H34ClFN8O | Details |
| Nilotinib Impurity14 | 851138-04-0 | Details |
| 1-(1-methyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)cyclopropane-1-carbonitrile | Details |
| Gepotidacin Impurity 19 | C22H24N6O3S | 1075236-71-3 | Details |
| Gepotidacin Impurity 15 | 1075236-88-2 | Details |
| Tofacitinib Impurity 06 | C20H18O8 | 32634-66-5 | Details |
| Ceritinib (LDK378) | C28H36ClN5O3S | 1032900-25-6 | Details |
| Ruxolitinib Impurity 27 | C17H18N6 | 941685-37-6 | Details |
| Enzalutamide Impurity10 | C17H8F6N4S | 1839619-50-9 | Details |
| Nilotinib Impurity16 | C19H15F3N4O3 | 1157857-29-8 | Details |
| Nilotinib Impurity06 | C24H17BrF3N5O | 1205540-16-4 | Details |
| Tofacitinib Impurity 05 | C14H17ClN2 | 1615709-90-4 | Details |
| Nilotinib Impurity17 | C17H15N5O | 851137-91-2 | Details |
| Seladelpar O-Desethyl Impurity | C19H19F3O5S | 851529-37-8 | Details |
| Nilotinib Impurity14 | C12H9F3N2O2 | 641571-13-3 | Details |
| Gepotidacin Impurity 16 | C24H28N6O3 | 1075236-87-1 | Details |
| Gepotidacin Impurity 24 | 1075236-57-5 | Details |
| Aztreonam Dimer Impurity 1 | C26H34N10O16S4 | Details |
| Glucosamine sulfate | C6H15NO9S | 14999-43-0 | Details |
| Tofacitinib citrate | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
| Nilotinib Impurity02 | C19H18N4O2 | 641569-97-3 | Details |
| Ruxolitinib Impurity 28 | C17H18N6 | 941688-05-7 | Details |
| Ruxolitinib Impurity 21 | C19H25N5O3 | 1146629-76-6 | Details |
| Enzalutamide Impurity11 | C10H7F3N2OS | 1895865-10-7 | Details |
| Guaiazulene Impurity7 | C15H19NaO4S | 65757-01-9 | Details |
| Osimertinib Impurity 10 | C27H33N7O | 1825290-88-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 | ||||